x 

0 Activities
0 Activities

Recommend to a friend

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

Watch coverage from the CHEST 2019 Annual Meeting for information regarding Pirfenidone in patients with unclassifiable interstitial lung disease. Click here!
No image set

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA